ClinicalTrials.gov
public full text
Public Domain
Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)
In a randomised placebo-controlled trial assess effects of zoledronic acid for prevention of bone and muscle loss after bariatric surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery#1093465
- Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males#979674
- Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis#1030042
- Real-time Optimized Biofeedback Utilizing Sport Techniques#1047066
- Effect of Alfacalcidol on Muscle Function in Osteoporosis Patients#1060883
Record · ID 874694
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive